Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of extended-release tofacitinib for alopecia areata
ChiCTR2400081744Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tofacitinib in alopecia areata, sponsored by West China Hospital of Sichuan University. Primary endpoint: Severity of alopecia areata. Started Mar 2024; status: recruiting.
02
Drugs
03
Conditions
alopecia areata
Beyond the preview
Go deeper on ChiCTR2400081744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081744.